SCP-8873
Safe
~
medium confidence
SCP-8873
Expected annual
$1.2M
One-time setup
$3.3M
Annual recurring
$1.1M
Personnel
11
One-time capital upgrades (MRI purchase, containment cell construction, HVAC retrofit, secure IT/CCTV) dominate upfront costs (~$3.3M), while recurring costs are driven by security and medical staffing, imaging/diagnostics, disposal, and cover/HR replacement (~$1.14M/yr). Contingency and optional MRI purchase are the largest sources of variance.
One-Time Capital Costs
Total: $3.3M
Annual Recurring Costs
Total: $1.1M/yr
Cost Scenarios
📊
Baseline
(baseline)
$1.1M/yr
Normal, uneventful year with two expected afflictions handled under routine protocols and no major incidents.
two expected cases handled
no cross-contamination or environmental spread
🚨
Minor Incident
$1.4M/yr
Single-year elevated response: unexpected cross-contamination or discovery of limited environmental viability requiring targeted remediation and external contractors.
limited environmental contamination
viable seed/pollen discovered onsite
🚨
Major Breach
$3.6M/yr
Significant environmental transmissibility or wider contamination necessitating large-scale quarantine, remediation, and public exposure mitigation.
environmental transmissibility confirmed
multiple uncontrolled offsite contaminations
Personnel
11 total
| Role | Count | Notes |
|---|---|---|
| Security Officer / MTF Agent | 8 | [#6] 8 guards to provide 24/7 coverage for two containment cells (rotating shifts); wages included in staff_wages. |
| Nursing / Medical Technician | 2 | [#7] Two full-time nurses dedicated to patient care; wages included in staff_wages. |
| Medical Officer / Neurologist | 1 | [#7] Part-time neurologist/physician coverage (modeled as single headcount for staffing accounting); wages included in staff_wages. |
Confidence Notes
Estimates are midpoints of analyst ranges and rely on assumptions about Site-19 capacity (MRI present vs purchased), staff counts, and two predictable annual cases. Capital decisions (buying an MRI, extent of retrofits) and future biological findings (seed/pollen viability) introduce moderate uncertainty.